Publications by authors named "Andre Ragnauth"

Claim this Profile
C
CK2-An Emerging Target for Neurological and Psychiatric Disorders.
Julia Castello, Andre Ragnauth, Eitan Friedman, Heike Rebholz

Pharmaceuticals (Basel)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taurine Targets the GluN2b-Containing NMDA Receptor Subtype.
Christopher Y Chan, Inderbir Singh, Heather Magnuson, Mohammad Zohaib, Kalindi P Bakshi, Andre Ragnauth

Adv Exp Med Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychopharmacological actions of taurine.
Shailesh P Banerjee, Andre Ragnauth, Christopher Y Chan, Mervan S Agovic, Vincent Sostris

Adv Exp Med Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased locomotor activity in mice lacking the low-density lipoprotein receptor.
Gregory A Elder, Andre Ragnauth, Nathan Dorr, Sonia Franciosi, James Schmeidler

Behav Brain Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
Aaron Juni, Gad Klein, Bill Kowalczyk, Andre Ragnauth, Benjamin Kest

Neuropharmacology· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice.
André K Ragnauth, Andrew Goodwillie, Cornelia Brewer, Louis J Muglia, Donald W Pfaff

Neuroendocrinology· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis